BioCentury
ARTICLE | Clinical News

Velcade bortezomib regulatory update

July 15, 2013 7:00 AM UTC

EMA's CHMP issued a positive opinion recommending extending the label of Velcade bortezomib from Johnson & Johnson to include induction treatment in combination with dexamethasone or with dexamethason...